Bionano Genomics BNGO Cash Flow Statement (2017-2026)

NASDAQ BNGO
$1.21 -0.02 (-1.63%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-20.75M-22.95M-29.95M-32.16M-31.81M-38.68M-37.12M-38.91M-112.57M-43.89M-31.42M-16.22M-44.25M-20.46M-3.10M-6.86M-8.50M18.52M-8.30M-7.42M
Depreciation and Depletion (Quarter)
-0.50M5.40M1.10M-1.10M1.00M1.00M
Share-based Compensation (Quarter)
0.18M2.44M0.51M0.00M21.90M3.88M3.93M3.99M3.37M3.02M2.58M2.20M1.94M1.59M1.08M0.94M0.93M0.67M0.97M
Gains from Investment Securities (Quarter)
0.07M0.08M0.08M0.08M0.08M0.79M1.43M0.31M-3.99M-0.64M-4.48M-5.77M
Asset Writedowns and Impairment (Quarter)
0.62M0.45M7.20M-0.42M
Cash from Operations (Quarter)
-19.98M-25.62M-32.49M-28.33M-29.47M-34.52M-32.41M-36.70M-26.29M-29.78M-28.13M-20.98M-13.31M-6.50M-2.76M-3.49M-5.92M-4.13M-5.70M-4.68M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
77.30M
Amortizatization of Intangibles (Quarter)
0.33M-0.30M-0.25M-0.14M0.06M0.05M0.05M0.05M0.39M0.69M0.22M-0.76M1.16M0.24M0.25M0.24M-0.52M0.19M0.11M
Amortization of Deferred Charges (Quarter)
0.20M0.30M0.04M0.05M-0.38M
Depreciation & Amortization (CF) (Quarter)
0.53M1.86M2.21M2.27M2.38M2.77M3.19M3.30M3.62M3.60M3.01M2.29M2.29M2.40M2.43M1.81M1.77M2.34M2.31M1.69M
Change in Working Capital
Change in Receivables (Quarter)
0.27M0.16M0.64M-0.66M1.16M1.12M-0.24M0.83M1.06M0.65M-1.00M-2.06M-0.94M-0.13M-1.40M0.14M1.03M0.67M-1.07M0.23M
Change in Inventory (Quarter)
6.74M5.58M5.94M6.16M6.03M5.55M5.71M1.64M-3.53M0.33M0.20M0.87M2.45M-2.93M-1.11M-0.72M-1.51M-1.57M0.11M-0.08M
Change in Account Payables (Quarter)
4.13M1.84M-3.17M1.09M0.84M3.18M3.02M-3.81M3.19M-4.40M-0.54M-1.11M-0.03M-1.74M-0.40M-0.32M-0.25M-0.40M-0.53M-0.50M
Change in Accured Expenses (Quarter)
3.02M-0.14M-0.44M-1.03M3.54M-1.70M-0.98M-1.09M3.04M-3.49M3.17M-5.25M0.39M-0.55M-0.49M-1.33M0.72M0.52M-1.42M-0.55M
Other Working Capital Changes (Quarter)
2.47M-0.75M0.05M-0.33M0.33M3.15M0.37M0.21M7.21M-9.01M-0.79M-0.34M0.79M-1.24M-0.07M0.03M-0.95M3.05M-0.34M0.03M
Investing Activities
Capital Expenditures (Quarter)
-0.08M0.64M0.83M-0.83M0.86M1.55M0.36M-0.26M0.33M1.26M0.03M0.08M-4.78M-0.33M0.33M-0.02M-0.57M
Sales of Property, Plant and Equipment (Quarter)
-0.13M0.03M-0.00M
Acquisitions (Quarter)
49.09M-0.69M32.04M
Change in Acquisitions & Divestments (Quarter)
20.00M66.48M47.18M46.30M41.91M65.50M16.89M29.99M37.99M52.15M158.17M69.74M57.36M21.70M50.70M53.85M56.22M68.36M54.13M45.14M
Cash from Investing Activities (Quarter)
-185.60M-92.51M31.96M31.24M7.95M11.61M16.53M29.58M33.43M-55.37M47.59M28.63M-5.38M3.00M-14.07M1.98M-4.67M4.01M5.46M13.68M
Financing Activities
Other financing activities (Quarter)
0.24M-0.06M0.01M0.14M0.11M0.08M0.02M0.08M0.00M0.01M-0.01M0.01M-0.01M
Cash from Financing Activities (Quarter)
13.77M1.97M0.01M0.20M22.65M0.15M14.86M17.88M12.59M68.48M-21.62M-1.98M6.02M3.89M10.89M1.47M10.08M1.60M0.66M-9.69M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
14.08M23.13M15.23M18.26M12.92M11.29M15.45M12.16M10.11M6.72M13.32M3.09M12.94M1.75M0.70M0.62M
Additional items
Exchange Rate Effect (Quarter)
-0.12M0.09M0.04M-0.01M-0.01M0.05M-0.03M-0.00M0.02M-0.00M-0.01M-0.02M0.01M0.01M0.01M0.00M
Change in Cash (Quarter)
-191.82M-116.17M-0.52M3.11M1.01M-22.68M-0.99M10.75M19.71M-16.62M-2.19M5.67M-12.64M0.38M-5.95M-0.06M-0.50M1.44M0.40M-0.68M
Free Cash Flow (Quarter)
-19.91M-26.26M-33.33M-27.50M-30.33M-36.07M-32.77M-36.44M-26.62M-31.04M-28.16M-21.05M-13.31M-1.72M-2.43M-3.82M-5.92M-4.13M-5.68M-4.11M
Net Cash Flow (Quarter)
-191.82M-116.17M-0.52M3.11M1.13M-22.76M-1.02M10.76M19.72M-16.67M-2.16M5.67M-12.66M0.38M-5.94M-0.04M-0.51M1.48M0.41M-0.70M